Literature DB >> 33768071

Beware of Drug Interactions Treating Iatrogenic Mycobacterium bovis Endocarditis from Intravesical BCG Instillation.

Francesca Curri1, Andrea Da Porto1, Viviana Casarsa1, Daria Albini1, Giorgio Minen2, Leonardo A Sechi1.   

Abstract

We report a case of mechanical mitral valve endocarditis associated with miliary disseminated bacillus Calmette-Guerin (BCG) infection following intravesical instillations for minimally invasive bladder cancer in a 65-year-old man. The diagnosis was established by echocardiographic evidence of vegetation on the prosthetic mitral valve, miliary lesions in the lungs and evidence of bloodstream infection sustained by Mycobacterium. We successfully treated the patient with the classical regimen of quadruple antituberculous therapy. LEARNING POINTS: To consider endocarditis as an extra-pulmonary manifestation of Mycobacterium bovis infection, especially in the presence of predisposing heart conditions and risk factors.To be careful of drug interactions among warfarin, rifampin and amiodarone. © EFIM 2021.

Entities:  

Keywords:  BCG; disseminated mycobacterial disease; infective endocarditis

Year:  2021        PMID: 33768071      PMCID: PMC7977042          DOI: 10.12890/2021_002263

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  7 in total

1.  Spectrum of bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy.

Authors:  Omar Y Gonzalez; Daniel M Musher; Indira Brar; Seth Furgeson; Maha R Boktour; Edward J Septimus; Richard J Hamill; Edward A Graviss
Journal:  Clin Infect Dis       Date:  2003-01-03       Impact factor: 9.079

2.  A case of infectious endocarditis due to BCG.

Authors:  Alice Fournier; Frédérique Gouriet; Pierre-Edouard Fournier; Jean-Paul Casalta; Ludivine Saby; Gilbert Habib; Michel Drancourt; Didier Raoult
Journal:  Int J Infect Dis       Date:  2015-04-11       Impact factor: 3.623

3.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

4.  Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.

Authors:  Krisztina A Nadasy; Rikin S Patel; Michael Emmett; Ricardo A Murillo; Marc A Tribble; Robert D Black; William L Sutker
Journal:  South Med J       Date:  2008-01       Impact factor: 0.954

5.  Steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity.

Authors:  H H Rotmensch; B Belhassen; B N Swanson; D Shoshani; S R Spielman; A J Greenspon; A M Greenspan; P H Vlasses; L N Horowitz
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

Review 6.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

7.  Blood culture-negative endocarditis: Improving the diagnostic yield using new diagnostic tools.

Authors:  Pierre-Edouard Fournier; Frédérique Gouriet; Jean-Paul Casalta; Hubert Lepidi; Hervé Chaudet; Franck Thuny; Frédéric Collart; Gilbert Habib; Didier Raoult
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.